This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Tairx, Inc.. Active years: 2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013
Title: The Innovations of Meng-Tung Tsai
Introduction
Meng-Tung Tsai is a notable inventor based in Taichung, Taiwan. He has made significant contributions to the field of chemistry, particularly in the development of compounds with potential anticancer properties. His work exemplifies the intersection of scientific research and practical application in medicine.
Latest Patents
Meng-Tung Tsai holds a patent for the "Synthesis and anticancer activity of aryl and heteroaryl-quinolin derivatives." This patent describes a compound of Formula I, which has been shown to exhibit promising anticancer activity. His innovative approach to synthesizing these compounds highlights his commitment to advancing cancer treatment options.
Career Highlights
Tsai is currently associated with Tairx, Inc., where he continues to engage in groundbreaking research. His work at Tairx, Inc. focuses on the development of novel therapeutic agents, contributing to the company's mission of improving healthcare through innovative solutions.
Collaborations
Throughout his career, Meng-Tung Tsai has collaborated with esteemed colleagues, including Sheng-Chu Kuo and Kuo-Hsiung Lee. These partnerships have fostered a collaborative environment that enhances the research and development process.
Conclusion
Meng-Tung Tsai's contributions to the field of chemistry and his innovative patent work demonstrate his dedication to advancing medical science. His efforts in developing anticancer compounds are a testament to the impact of research and innovation in improving health outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile